Recently Approved Drug by U.S FDA

The United States Food and Drug Administration (FDA) has approved Uloric (febuxostat) 40 mg and 80 mg for the chronic management of hyperuricemia in patients with gout.

Generic Name: febuxostat
Date of Approval: February 13, 2009
Company: Takeda Pharmaceutical Company Limited